GlassScriptPhysician profile
Sylvia Olison
NPI 1518795293
$2,181.67
in general payments reported to CMS, 2019-2025
11 companies · $1,151 in 2025
The $1,151 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,030 · 2025: $1,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,589 · Travel and Lodging: $548 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,589.08 |
| Travel and Lodging | $547.59 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,004.42 | 2024-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $410.12 | 2025 | Intracept, Wavewriter Alpha Prime 16 |
| Electronic Waveform Lab, INC. | $263.92 | 2025 | |
| Globus Medical, INC. | $123.99 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $80.63 | 2024-2025 | Xtampza, Belbuca |
| Vertex Pharmaceuticals Incorporated | $77.13 | 2024-2025 | |
| Si-Bone, INC. | $75.68 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.46 | 2025 | Relistor |
| Scilex Pharmaceuticals INC. | $36.67 | 2025 | |
| Ibsa Pharma INC. | $24.99 | 2024 | Licart, Tirosint |
| Spinal Simplicity, LLC | $17.66 | 2025 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sylvia Olison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.